Here's what's actually happening right now.
Drug companies spend billions deciding which medicines to develop, which ones to kill, and how to get them approved. They need the best information possible. Here's what they're actually getting:
of healthcare executives don't trust their AI tools
spent every year on healthcare intelligence that's mostly guesswork
other companies that verify AI outputs before delivering them
AI is making things up and no one is checking.
The Hallucination Problem
When you ask ChatGPT or similar tools a question, they sometimes invent answers that sound completely real but are 100% fake. They'll cite studies that don't exist. They'll quote numbers they made up. In healthcare, this isn't just annoying — it can cost lives and billions of dollars.
Generic AI (ChatGPT etc.) 🤔
❌ Fake citation made up
❌ Wrong drug data
❌ Invented statistics
→ Board Presentation
Billion-dollar decisions made here
The Knowledge-Walking-Out-The-Door Problem
When a senior scientist or regulatory expert leaves a drug company, everything they knew goes with them. All the context about why certain decisions were made, what the FDA said in private meetings, which competitors to watch — gone. Poof. The company has to start over.
Drug Company
FDA context · Competitor info · Deal rationale · Strategy
🚶 Senior scientist leaves
Company after: 😶
Starting from zero
AimwellBio built a system that actually checks.
Think of it like this: if ChatGPT is a student who makes stuff up on a test, AimwellBio's system (called Cortex) is the teacher who checks every answer against the textbook before handing it in.
How Cortex Works (Simply)
Cortex watches what's happening across healthcare — FDA decisions, new drug trials, competitor moves, medical research. When someone asks a question, it gives an answer AND shows exactly where that answer came from. If it can't verify something, it says "I don't know" instead of guessing.
REAL SOURCES
FDA Database · Clinical Trials · Patent Filings · Research Papers · Market Signals
↓
Cortex
Verifies every answer · Traces to real sources · Never makes things up
OUTPUT
✅ Verified Intelligence (with source links)
✅ Change Alerts (things that changed)
✅ Decision Briefings (ready for the boardroom)
Why AimwellBio is different from everything else.
There are other companies in this space. Here's why they're not solving the problem — and why AimwellBio is.
| What Matters | Everyone Else | AimwellBio |
|---|---|---|
| Checks if answers are real | ❌ Nope. Trust us, bro. | ✅ Every answer traced to source |
| Watches for changes across sources | ❌ Quarterly reports (months late) | ✅ Monitored across sources |
| Remembers past decisions | ❌ Lost when people leave | ✅ Institutional memory built in |
| Gets smarter over time | ❌ Same service year after year | ✅ Learns your specific context |
| Built for healthcare | ❌ Generic tools repurposed | ✅ Purpose-built from day one |
| Cost | ❌ $500K+ for consulting firms | ✅ Starts at $279/month |
The Competition Landscape
ChatGPT & Co.
Smart but makes stuff up · No healthcare expertise
⚠ HALLUCINATION RISK
McKinsey etc.
Expensive. Slow. Static. Reports already outdated
⚠ $500K+ PER REPORT
Veeva, IQVIA
Data, but not intelligence · You still have to figure it out
⚠ RAW DATA, NO ANSWERS
➔ AimwellBio
✅ Source-traced (no hallucinations)
✅ Regularly updated
✅ Improves over time
✅ Affordable ($279/mo)
✅ Built for healthcare
Built by the generation that grew up with AI.
AimwellBio doesn't just use AI — it's built by young, AI-native researchers who understand both the power and the danger. They're not trying to replace scientists. They're making sure their own work is used to save people, not mislead them.
They Built the Verification Layer
Instead of just asking AI for answers, they built a system that checks every answer against real sources before it reaches anyone. This is the part no one else has. It's the difference between a search engine and a fact-checked newspaper.
They Know AI's Weaknesses
Growing up with AI means they know exactly where it fails. They've seen the hallucinations, the confident wrong answers, the fake citations. They built Cortex specifically to catch and prevent every one of those failure modes.
Mission: Save Humanity From Bad AI
This isn't just a business play. When healthcare AI hallucinates, real patients can be harmed. These researchers are building the guardrail that the entire industry needs — not because it's profitable (it is), but because it's necessary.
What happens if no one fixes this problem?
WITHOUT AIMWELLBIO:
⚠️ AI hallucinates a drug study
⚠️ Nobody catches the error
⚠️ Company makes wrong decision
⚠️ Based on fake information
⚠️ Patients harmed. Billions lost.
WITH AIMWELLBIO:
✅ AI checked. Error caught.
✅ Correct data used instead
✅ Lives saved. Money saved.
The four words that matter on this platform.
AimwellBio has a small, specific vocabulary. Understanding these four terms is all you need to understand how the system works.
A credentialed professional with read access to FHIN-verified intelligence.
Physicians, researchers, regulatory professionals, and HEOR specialists who join the platform to monitor decision signals relevant to their work. Observers do not contribute data — they consume verified output. Observer status is free and requires credential verification.
Field Health Intelligence Network — the contributor layer beneath the platform.
FHIN is the network of verified subject matter experts whose structured contributions are used to audit and validate AI-generated biopharma intelligence. FHIN contributors are invited based on domain expertise. They are not employees. Their contributions are anonymized and aggregated before any output is generated.
A structured, source-anchored data point that has passed adversarial review.
A signal is not a rumor, a trend, or an opinion. It is a discrete piece of intelligence that has been traced to a primary source (FDA database, clinical trial registry, patent filing, or FHIN contributor input) and validated by at least one adversarial audit agent before being surfaced.
The three-state output of the Cortex adversarial audit: PROCEED, DELAY, or KILL.
Every brief run through Cortex returns one of three verdicts. PROCEED means the brief passed all four audit agents with no material conflicts. DELAY means one or more agents flagged an issue requiring resolution before a decision should be made. KILL means the brief contains a fundamental flaw — incorrect data, regulatory conflict, or unresolvable hallucination.
What AimwellBio does not claim.
Honest disclosure of what this platform is — and isn't — is itself a form of intelligence integrity.
Not medical advice
AimwellBio does not provide clinical recommendations for individual patients. Nothing on this platform should be used as a basis for treatment decisions.
Not investment advice
Intelligence briefings and verdicts do not constitute financial or investment recommendations. AimwellBio does not hold positions in any companies discussed on this platform.
Not error-free
Adversarial validation significantly reduces hallucination risk, but does not eliminate it. Source data is only as current as its upstream database. PROCEED verdicts are confidence indicators, not guarantees.
Not a replacement for experts
Cortex is a decision support layer, not a decision maker. The professional judgment of your regulatory, clinical, and BD teams remains the authoritative input. AimwellBio augments their work — it does not replace it.
You get it now. So which tier is actually built for your week?
Pick the line that sounds like your job, not a feature table. Each path goes to the tier built for that work — with honest labels on what is active today and what activates during onboarding.
Analyst / Medical Affairs
“I run verdicts against named entities every week.”
Member gives you AIMN:VERDICT on a regular cadence, a private vault, and branded export. Verdict generation and vault are active today.
See Member →BD / Investor / Board-facing
“I cannot afford to be surprised in a memo.”
Shield is built so every signal in a board memo is defensible. Competitor monitoring is in activation and is configured during onboarding.
See Shield →Team / Department Lead
“My team decides together and needs governance.”
Command is sales-assisted and configured with Aimwell review before activation — seats, a shared decision trail, and governance. Not a self-serve checkout.
Request Command Access →Credentialed Professional
“I want to see it work before I pay anything.”
Start as an Observer — sample verdicts with full citation-resolution gating, no payment, no sales call. The reference tier for seeing the standard first.
Start as an Observer →Not sure yet? Preview every tier dashboard → Sample data in previews is labeled Sample; live data connects in your environment after onboarding.
Now you get it. The question is whether anyone has challenged your brief.
Healthcare intelligence needs a verification layer. Be the team that built it first. Run an adversarial audit before your next submission.